2gbf: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="2gbf" size="450" color="white" frame="true" align="right" spinBox="true" caption="2gbf, resolution 3.100Å" /> '''rat dpp-IV with alk...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2gbf.gif|left|200px]]<br /><applet load="2gbf" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:2gbf.gif|left|200px]]<br /><applet load="2gbf" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="2gbf, resolution 3.100&Aring;" />
caption="2gbf, resolution 3.100&Aring;" />
'''rat dpp-IV with alkynyl cyanopyrrolidine #1'''<br />
'''rat dpp-IV with alkynyl cyanopyrrolidine #1'''<br />


==Overview==
==Overview==
Dipeptidyl peptidase IV (DPP-IV) belongs to a family of serine peptidases, and due to its indirect regulatory role in plasma glucose modulation, DPP-IV has become an attractive pharmaceutical target for diabetes, therapy. DPP-IV inactivates the glucagon-like peptide (GLP-1) and several, other naturally produced bioactive peptides that contain preferentially a, proline or alanine residue in the second amino acid sequence position by, cleaving the N-terminal dipeptide. To elucidate the details of the active, site for structure-based drug design, we crystallized a natural source, preparation of DPP-IV isolated from rat kidney and determined its, three-dimensional structure using X-ray diffraction techniques. With a, high degree of similarity to structures of human DPP-IV, the active site, architecture provides important details for the design of inhibitory, compounds, and structures of inhibitor-protein complexes offer detailed, insight into three-dimensional structure-activity relationships that, include a conformational change of Tyr548. Such accommodation is, exemplified by the response to chemical substitution on 2-cyanopyrrolidine, inhibitors at the 5 position, which conveys inhibitory selectivity for, DPP-IV over closely related homologues. A similar conformational change is, also observed in the complex with an unrelated synthetic inhibitor, containing a xanthine core that is also selective for DPP-IV. These, results suggest the conformational flexibility of Tyr548 is unique among, protein family members and may be utilized in drug design to achieve, peptidase selectivity.
Dipeptidyl peptidase IV (DPP-IV) belongs to a family of serine peptidases, and due to its indirect regulatory role in plasma glucose modulation, DPP-IV has become an attractive pharmaceutical target for diabetes therapy. DPP-IV inactivates the glucagon-like peptide (GLP-1) and several other naturally produced bioactive peptides that contain preferentially a proline or alanine residue in the second amino acid sequence position by cleaving the N-terminal dipeptide. To elucidate the details of the active site for structure-based drug design, we crystallized a natural source preparation of DPP-IV isolated from rat kidney and determined its three-dimensional structure using X-ray diffraction techniques. With a high degree of similarity to structures of human DPP-IV, the active site architecture provides important details for the design of inhibitory compounds, and structures of inhibitor-protein complexes offer detailed insight into three-dimensional structure-activity relationships that include a conformational change of Tyr548. Such accommodation is exemplified by the response to chemical substitution on 2-cyanopyrrolidine inhibitors at the 5 position, which conveys inhibitory selectivity for DPP-IV over closely related homologues. A similar conformational change is also observed in the complex with an unrelated synthetic inhibitor containing a xanthine core that is also selective for DPP-IV. These results suggest the conformational flexibility of Tyr548 is unique among protein family members and may be utilized in drug design to achieve peptidase selectivity.


==About this Structure==
==About this Structure==
2GBF is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with AIA as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Dipeptidyl-peptidase_IV Dipeptidyl-peptidase IV], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.14.5 3.4.14.5] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2GBF OCA].  
2GBF is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus] with <scene name='pdbligand=AIA:'>AIA</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/Dipeptidyl-peptidase_IV Dipeptidyl-peptidase IV], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.14.5 3.4.14.5] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2GBF OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Rattus norvegicus]]
[[Category: Rattus norvegicus]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Fry, E.H.]]
[[Category: Fry, E H.]]
[[Category: Jakob, C.G.]]
[[Category: Jakob, C G.]]
[[Category: Longenecker, K.L.]]
[[Category: Longenecker, K L.]]
[[Category: Wilk, S.]]
[[Category: Wilk, S.]]
[[Category: AIA]]
[[Category: AIA]]
[[Category: serine peptidase beta propeller]]
[[Category: serine peptidase beta propeller]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 11:05:47 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:30:00 2008''